July 6, 2018

Please reload

Recent Posts

FDA Comments on Recently Released Rare Disease Guidance for Industry

September 16, 2015

Jonathan Goldsmith, M.D., F.A.C.P., FDA’s Associate Director, Rare Diseases Program, Center for Drug Evaluation and Research, comments on the recently...

Please reload

Featured Posts

FDA Commissioner Gottlieb Outlines Efforts to Advance Biotechnology Innovation

June 12, 2018

In a recent blog post from the FDA, Commissioner Scott Gottlieb acknowledges their role to help advance progress in biotechnology.  Their approach will focus on three key areas: "First, advancing and protecting public and animal health by promoting innovation through an efficient and predictable science- and risk-based regulatory framework; second, strengthening public outreach and communication through strong, effective and transparent engagement with stakeholders; and third, increasing engagement with domestic and international partners through coordinated and collaborative actions to support regulatory alignment and efficiency."


We are excited to see FDA's continued interest in innovation as new technologies and research advance solutions for patients in need.  


To read the full blog entry, follow the link below:  https://blogs.fda.gov/fdavoice/index.php/2018/06/fdas-new-efforts-to-advance-biotechnology-innovation/

Please reload

Patagonia Pharmaceuticals, LLC

50 Tice Blvd, Suite A26

Woodcliff Lake, NJ 07677

For more info: info@patagoniarx.com

© 2019 by Patagonia Pharmaceuticals, LLC